Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study

Summary Background: Delta virus (HDV)‐related chronic hepatitis is difficult to treat. Aims: To evaluate the efficacy of lamivudine 100 mg daily on serum HDV‐RNA, hepatitis D virus antibodies and alanine aminotransferase levels, liver histology, and on hepatitis B surface antigen seroconversion. M...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2005-08, Vol.22 (3), p.227-232
Hauptverfasser:	NIRO, G. A., CIANCIO, A., TILLMAN, H. L., LAGGET, M., OLIVERO, A., PERRI, F., FONTANA, R., LITTLE, N., CAMPBELL, F., SMEDILE, A., MANNS, M. P., ANDRIULLI, A., RIZZETTO, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Viral - blood Antiviral Agents - therapeutic use Biological and medical sciences Digestive system Double-Blind Method Female Gastroenterology. Liver. Pancreas. Abdomen Hepatitis B Surface Antigens - blood Hepatitis D, Chronic - drug therapy Hepatitis D, Chronic - pathology Hepatitis D, Chronic - virology Hepatitis Delta Virus - immunology Hepatitis Delta Virus - isolation & purification Humans Lamivudine - therapeutic use Male Medical sciences Middle Aged Pharmacology. Drug treatments Reverse Transcriptase Inhibitors - therapeutic use RNA, Viral - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!